Guyasuta Investment Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-12,300
Closed -$203K 205
2018
Q3
$203K Hold
12,300
0.02% 212
2018
Q2
$206K Buy
+12,300
New +$199K 0.02% 210
2018
Q1
Sell
-12,300
Closed -$232K 223
2017
Q4
$232K Hold
12,300
0.03% 208
2017
Q3
$359K Hold
12,300
0.04% 164
2017
Q2
$396K Hold
12,300
0.05% 151
2017
Q1
$426K Hold
12,300
0.05% 156
2016
Q4
$434K Hold
12,300
0.06% 144
2016
Q3
$427K Hold
12,300
0.05% 147
2016
Q2
$459K Hold
12,300
0.06% 137
2016
Q1
$497K Hold
12,300
0.07% 134
2015
Q4
$442K Hold
12,300
0.06% 141
2015
Q3
$392K Hold
12,300
0.06% 152
2015
Q2
$418K Hold
12,300
0.06% 162
2015
Q1
$416K Hold
12,300
0.06% 153
2014
Q4
$431K Hold
12,300
0.06% 151
2014
Q3
$402K Hold
12,300
0.06% 151
2014
Q2
$417K Hold
12,300
0.06% 151
2014
Q1
$430K Hold
12,300
0.06% 147
2013
Q4
$449K Hold
12,300
0.07% 144
2013
Q3
$425K Hold
12,300
0.07% 142
2013
Q2
$416K Buy
+12,300
New +$408K 0.07% 135

Other funds holding ACH

Guyasuta Investment Advisors's ACH Position: Q4 2018 in Review

Guyasuta Investment Advisors sold out of Accendra Health (ACH) in Q4 2018, closing a stake of 12,300 shares — an estimated $203K sold.

Guyasuta Investment Advisors first reported a position in ACH in Q2 2013 and held it in 21 quarters. The position peaked at $497K in Q1 2016. 210 funds tracked by Wall St. Rank hold ACH as of Q4 2018.

  • Guyasuta Investment Advisors reported no remaining Accendra Health position as of Q4 2018 after selling out during the quarter.
  • Guyasuta Investment Advisors sold 12,300 Accendra Health shares in Q4 2018, an estimated $203K.
  • Guyasuta Investment Advisors first reported a position in Accendra Health in Q2 2013 and held it in 21 quarters.
  • Guyasuta Investment Advisors's Accendra Health position peaked at $497K in Q1 2016.
  • 210 funds tracked by Wall St. Rank held Accendra Health as of Q4 2018.

Based on Guyasuta Investment Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.